James N Kochenderfer, M.D.
National Cancer Institute (NCI)
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name James N Kochenderfer, M.D. as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 13:19 UTC. Open this list on ClinicalTrials.gov
- Ph1NCT06904066 · Autologous T Cells Transduced With Retroviral Vectors Expressing TCRs for Participant-specific Neoantigens in Patients With Hematologic MalignanciesNational Cancer Institute (NCI) · recruiting · Malignancy, Hematologic, Neoplasms, Hematologic, Neoplasms, Hematopoietic · principal investigator
- Ph1/Ph2NCT06364423 · Anti-CD19 Chimeric Antigen Receptor T-Cell Immunotherapy for LeukemiasNational Cancer Institute (NCI) · recruiting · Leukemia, Lymphocytic, Chronic, B-Cell, B-Lymphocytic Leukemia, Chronic, B-Cell Chronic Lymphocytic Leukemia · principal investigator
- Ph1NCT05797233 · Trial of Anti-CD19 and Anti-CD20 Bicistronic Chimeric Antigen Receptor T Cells for Treating B-Cell MalignanciesNational Cancer Institute (NCI) · active not recruiting · Chronic Lymphocytic Leukemia, B-Cell Chronic Lymphocytic Leukemia, Lymphoma, B-Cell · principal investigator
- Ph1NCT04160195 · T Cells Expressing Fully-human Anti-CD19 and Anti-CD20 Chimeric Antigen Receptors for Treating B-cell Malignancies and Hodgkin LymphomaNational Cancer Institute (NCI) · terminated · Lymphoma, B-Cell, Lymphoma, Non-hodgkins, Chronic Lymphocytic Leukemia · principal investigator
- Ph1NCT03958656 · T-cells Expressing an Anti-SLAMF7 CAR for Treating Multiple MyelomaNational Cancer Institute (NCI) · completed · Myeloma-Multiple, Myeloma, Plasma-Cell · principal investigator
- Ph1NCT03602612 · T Cells Expressing a Novel Fully-Human Anti-BCMA CAR for Treating Multiple MyelomaNational Cancer Institute (NCI) · completed · Myeloma-Multiple, Myeloma, Plasma-Cell · principal investigator
- Ph1NCT03049449 · T Cells Expressing a Fully-Human Anti-CD30 Chimeric Antigen Receptor for Treating CD30-Expressing LymphomasNational Cancer Institute (NCI) · completed · Lymphoma, Large-Cell, Anaplastic, Enteropathy-Associated T-Cell Lymphoma, Lymphoma, Large B-Cell, Diffuse · principal investigator
- Ph1NCT02659943 · T Cells Expressing a Fully-human AntiCD19 Chimeric Antigen Receptor for Treating B-cell MalignanciesNational Cancer Institute (NCI) · completed · Lymphoma, B-Cell, Lymphoma, Non-hodgkins · principal investigator
- N/ANCT02473757 · Gene Therapy Follow-up Protocol for People Previously Enrolled in CAR-T Cell StudiesNational Cancer Institute (NCI) · enrolling by invitation · Lyphoma, B-Cell, Leukemia, B-cell, Multiple Myeloma · principal investigator
- Ph1NCT02215967 · Study of T Cells Targeting B-Cell Maturation Antigen for Previously Treated Multiple MyelomaNational Cancer Institute (NCI) · completed · Myeloma, Plasma-Cell, Myeloma-Multiple · principal investigator
- Ph1NCT01087294 · Administration of Anti-CD19-chimeric-antigen-receptor-transduced T Cells From the Original Transplant Donor to Patients With Recurrent or Persistent B-cell Malignancies After Allogeneic Stem Cell TransplantationNational Cancer Institute (NCI) · completed · Leukemia, B-cell, Lymphoma, Hodgkins, Lymphoma, Non-hodgkins · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 13:19 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 19 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in childhood acute lymphoblastic leukemia.